Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
China Pharmacy ; (12): 1622-1626, 2021.
Article in Chinese | WPRIM | ID: wpr-881466

ABSTRACT

OBJECTIVE:To investig ate the application and trend o f tranexamic acid in the orthopedic inpatient ,and to provide reference for rational drug use. METHODS :The consumption of tranexamic acid ,the distribution of orthopedics diseases using tranexamic acid and route of administration were analyzed in 3 sub-departments (joint surgery department ,spinal surgery department,orthopedic trauma department )from 4 third-grade class-A hospitals of Chongqing during 2017 to 2020. RESULTS : The total consumption of tranexamic acid used in orthopaedic department had increased year by year in the past 4 years,with increase of 6.2%-52.2%,and the consumption of tranexamic acid in various departments also increased year by year ;from 2017 to 􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂􀤂 书辅料标明情况及风险控制建议 [J].中国药师,2018,21 中华中医药杂志,2018,33(6):2225-2229. (18):2020-2022. [10] 孟菲,李学林.中成药说明书中规格项存在的问题与探 [ 7 ] 国家药典委员会.中华人民共和国药典:二部[S]. 2010年 讨[J].当代医学,2015,21(12):14-15. 版.北京:中国医药科技出版社,2010:1014. [11] 国家食品药品监督管理局 .中成药规格表述技术指导原 [ 8 ] 孟菲,李学林.中成药说明书中功能主治项表述方法的探 则:征求意见稿 [EB/OL].(2017-10-11)[2020-12-20]. 讨[J].中医药临床杂志,2015,27(1):111-112. https://www.nmpa.gov.cn/xxgk/zhqyj/zhqyjyp/20171011- [ 9 ] 田硕,郭晖,苗明三.中成药说明书完善的思考及实践[J]. 151401184.html. [12] 王裴芳.我国中成药说明书中老年人用药项的调查分 Δ基金项目:重庆市科技计划项目-技术预见与制度创新项目(No. 析[J].中国药房,2015,26(29):4055-4057. cstc2018jsyj-zdcxX0052);重庆市社会科学规划项目(No.2019QNGL31) [13] 林志健,周伟龙,张冰,等.中成药说明书中儿童用药信息 *硕士研究生 。研究方向 :社会医学 、卫生事业管理 。电话: 023-68485178。E-mail:351389583@qq.com 的修订完善思考 [J].药物流行病学杂志 ,2018,27(4): # 通信作者:教授,硕士生导师,硕士。研究方向:医事法学、卫生 244-248. 政策、卫生事业管理。电话:023-68485178。E-mail:puchuan68@sina. (收稿日期:2021-01-07 修回日期:2021-05-26) com (编辑:罗 瑞) ·1622· China Pharmacy 2021Vol. 32 No. 13 中国药房 2021年第32卷第13期 2019,joint surgery department accounted for the largest prop ortion(59.2% ,53.5% ,47.2%)to use tranexamic acid ,and orthopedic trauma department accounted for the largest proportion (39.2%)in 2020. On the whole ,top 4 orthopedic diseases in the list of the consumption of tranexamic acid were joint replacement (25.5%-29.6%),hip fracture (19.3%-23.6%),diaphysis fracture (13.5%-18.6%)and pelvic and acetabular fracture (8.2%-14.0%). The route of administration for tranexamic acid in spinal surgery department ,joint surgery department and orthopedic trauma department was mainly intravenous application every year (accounting for 55.1%-81.0%,46.9%-77.1%,49.3%-73.3%,44.9%-71.5%). CONCLUSIONS :The consumption of tranexamic acid in orthopedic inpatients is increased year by year ,and is dominated by joint surgery department and orthopedic trauma department. The route of tranexamic acid is still mainly intravenous administration ,which is safe and reliable.

2.
China Pharmacy ; (12): 623-629, 2021.
Article in Chinese | WPRIM | ID: wpr-873680

ABSTRACT

OBJECTIVE:To establish quantitative e valuation system of the prophylactic use of antibiotics in orthopedic type Ⅰ incision surgery ,and to provide reference for evaluating the rational prevention use of antibiotics in this type surgery scientifically. METHODS:Based on the Guidelines of Clinical Use of Antimicrobial Agents (2015 edition),drug instructions ,related guidelines and references ,experts from relevant departments jointly discussed and formulated the evaluation criteria for the rationality of the use of antibiotics in type Ⅰ incision in orthopedic surgery. AHP method was used to assign the weights for various indexes of evaluation criteria ;TOPSIS method was used to retrospectively analyze and evaluate the rationality of 120 cases of type Ⅰ incision surgery from 3 orthopedic departments in Peking University People ’s Hospital during Sept. 1st-30th,2019. RESULTS :Established evaluation system included 4 primary indicators (medication indication ,usage and dosage ,medication timing ,other factors )and 12 secondary indicators. Among the secondary indicators ,indications,drug selection and timing of preoperative administration were the most important (weights were 0.209,0.140,0.117). Among 120 cases,30.83% of drug use were reasonable ,47.50% were basically reasonable and 21.67% were unreasonable. Evaluation results obtained by AHP-TOPSIS were consistent with the actual situation. CONCLUSIONS :The rationality evaluation method of prophylactic use of antibiotics in type Ⅰ incision surgery based on AHP-TOPSIS method can quantitatively evaluate the rationality of drug use by combining multiple indicators. The method is feasible ,operable,and the evaluation results can be quantified ,which has a wide range of application.

3.
Chinese Journal of Infection Control ; (4): 60-62, 2015.
Article in Chinese | WPRIM | ID: wpr-462099

ABSTRACT

Objective To understand the distribution and antimicrobial resistance of pathogens isolated from bone and joint infection sites of orthopedic patients,so as to provide reference for prevention and therapy of bone and joint infection.Methods 114 specimens from bone and joint infection sites of orthopedic patients between June 2010 and October 2013 were surveyed,pathogens and antimicrobial susceptibility of pathogens were analyzed.Results A total of 145 pathogenic isolates were obtained,62.07%(n=90)of which were gram-negative bacteria,34.48%(n=50)were gram-positive bacteria,2.07%(n=3)were Candida spp .,and 1 .38%(n =2)were anaerobic bacteria. The top 4 pathogens were Pseudomonas aeruginosa (20.69%),Staphylococcus aureus (12.41 %),Escherichia coli (11 .03 %),and Enterobacter cloacae (9.65%).These pathogens presented remarkable resistance.The resistant rate of Pseudomonas aeruginosa to ceftazidime was up to 40.00%;the resistant rates of Escherichia coli to com-pound sulfamethoxazole,ciprofloxacin and levofloxacin were all 100.00%.Conclusion Gram-negative bacteria are the major pathogens in orthopedic ward,the isolated strains are resistant to multiple antimicrobial agents.

SELECTION OF CITATIONS
SEARCH DETAIL